Article Versions Notes

Yano K, Seko Y, Takahashi A, Okishio S, Kataoka S, Takemura M, Okuda K, Mizuno N, Taketani H, Umemura A, et al. Effect of Sodium Glucose Cotransporter 2 Inhibitors on Renal Function in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes in Japan. Diagnostics. 2020; 10(2):86. https://doi.org/10.3390/diagnostics10020086

Yano, Kota, Yuya Seko, Aya Takahashi, Shinya Okishio, Seita Kataoka, Masashi Takemura, Keiichiroh Okuda, Naoki Mizuno, Hiroyoshi Taketani, Atsushi Umemura, and et al. 2020. "Effect of Sodium Glucose Cotransporter 2 Inhibitors on Renal Function in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes in Japan" Diagnostics 10, no. 2: 86. https://doi.org/10.3390/diagnostics10020086

Yano, K., Seko, Y., Takahashi, A., Okishio, S., Kataoka, S., Takemura, M., Okuda, K., Mizuno, N., Taketani, H., Umemura, A., Nishikawa, T., Yamaguchi, K., Moriguchi, M., Okanoue, T., & Itoh, Y. (2020). Effect of Sodium Glucose Cotransporter 2 Inhibitors on Renal Function in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes in Japan. Diagnostics, 10(2), 86. https://doi.org/10.3390/diagnostics10020086